TDM-105795 is a topical Thyroid-Receptor beta-1 agonist currently in clinical trial for hair growth. It is developed by Technoderma, a Chinese company founded by ex-Pfizer employees.
Previous research on such a substance has been, among others, conducted by Pfizer and Ralf Paus' Monasterium Lab...